Author's posts
In Baltimore, nurses go door-to-door to bring primary care to the whole neighborhood
A cadre of Johns Hopkins nurses are adapting a model for primary care that’s been successful in Costa Rica. They will visit every household in a Baltimore community to assess health care and social needs at least once a year.
Medicare shoppers often face a barrage of unsolicited calls and aggressive ads
Medicare’s annual open enrollment period began Oct. 15, allowing seniors to choose new plans. New rules this year are supposed to crack down on misleading marketing but buyers should still beware.
She has Medicare and Medicaid. So why should it take 18 months to get a wheelchair?
About 12 million Americans are known as “dual eligibles” because they need both Medicare and Medicaid. A bipartisan bill offers hope to cut through the tangle of red tape that often ensnares them.
What’s a fair price for a prescription drug? Medicare’s about to weigh in
Medicare soon will start something it hasn’t done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
Medicare tests a solution to soaring hospice costs: Let private insurers run it
The end-of-life benefit costs billions a year. A new approach aims to eliminate waste and weed out bad actors, while making the care more inviting to those who most need it.
AbbVie’s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.
